Novo Nordisk Stock - Search News

Novo Nordisk, Foreign Dividend Stocks

Novo Nordisk ( NVO -1.22%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, beginning with a 3% decline on Monday from last Friday's close, and falling another 2.6% through 10:10 a.m. ET on Thursday.

Hosted on MSN · 1d

Is Novo Nordisk A/S (NVO) the Best Foreign Dividend Stock to Buy According to Analysts?

We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other foreign dividend stocks.

Seeking Alpha · 2d

Novo Nordisk: Dips Like These Come Once Every Few Years

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy with promising growth in obesity care.

Wall Street Journal · 10d

Novo Nordisk Earnings Boost Stock in Ozempic Maker

Novo Nordisk stock gained, lifted by strong sales growth and guidance from the maker of Wegovy and Ozempic. Shares in Novo, one of Europe's largest listed companies, advanced nearly 3% in Denmark. Dig

Investing.com on MSN · 3d

Bernstein raises Novo Nordisk stock target to DKK620

Bernstein analysts led by Florent Cespedes increased their price target on Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO) stock to DKK620.00, up from DKK600.00, while maintaining a Market Perform rating. The $365 billion market cap company,

1don MSN

Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

1don MSN

Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

19h

Novo Nordisk A/S (NYSE:NVO) Coverage Initiated by Analysts at Morgan Stanley

Morgan Stanley began coverage on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a research report released on ...

10don MSN

Novo Nordisk Stock Rises as Q4 Wegovy Sales More Than Double

Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...

Novo Nordisk: 2024 Earnings Review

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

How Is The Market Feeling About Novo Nordisk?

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

If you purchased Novo Nordisk securities during the Class Period you may be entitled to compensation without payment of any ...

Is Novo Nordisk's Bottom Here? Oversold Status Below 10Y P/E Lows

Novo Nordisk faces challenges but its pipeline remains strong. Find out why NVO stock could deliver high double-digit returns ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Novo Nordisk, Foreign Dividend Stocks

Related topics